If you've just had Ultrasound-Guided Sclerotherapy (UGS), your clinician probably handed you a list of post-care instructions and said something like: "Walk for 30 minutes straight after the procedure. Wear your compression stockings for two weeks. No long-haul flights or heavy gym sessions."
Simple enough, right?
Except most people hear those rules and think, "Do they really matter that much?"
They do. And the reason why comes down to something much more precise than general caution—it's haemodynamics.
To understand why recovery protocol exists the way it does, it helps to understand what sclerotherapy is actually doing at a vascular level.
UGS involves injecting a sclerosing agent—typically a foamed solution of polidocanol or sodium tetradecyl sulphate—directly into a diseased vein under ultrasound guidance. The chemical irritates the endothelial lining of the vessel wall, triggering an inflammatory cascade that causes the vein to spasm, collapse, and eventually fibrosis into a non-functional cord of scar tissue.
That conversion process—from open, blood-carrying vessel to inert fibrous tissue—doesn't happen overnight. It unfolds over days to weeks. And what you do in that window has a direct bearing on two things: the risk of Deep Vein Thrombosis (DVT), and how cleanly the treated vein resolves.
That's why post-procedure behaviour isn't optional. It's physiologically active.
The instruction to walk immediately after the procedure surprises some patients. They assume rest would make more sense.
It doesn't—and here's why.
Your legs contain two venous systems: a superficial network close to the skin (the one UGS targets), and a deep venous network buried within the muscle compartments. These systems communicate through perforating veins that act as one-way valves.
When a superficial vein is sclerosed and taken offline, the blood that previously travelled through it needs somewhere to go. It reroutes—through perforating veins—into the deep venous system.
Venous stasis is one of three components of Virchow's Triad—the classic clinical framework for understanding DVT formation. The triad identifies stasis, hypercoagulability, and endothelial injury as the three conditions that together create clot risk. After UGS, endothelial injury is a given—that's the mechanism of the treatment. Hypercoagulability is present to some degree simply because the body is responding to the chemical insult. What you can actively control is stasis.
This is addressed directly by walking. With every step, the calf muscles act as a peripheral venous pump, contracting and squeezing the deep veins, pushing blood up toward the heart. Research published in Phlebology and consistent with findings from the American Venous Forum shows that when the calf muscle pump is activated, deep venous flow velocity is significantly increased and venous transit time is reduced. Post-sclerotherapy patients have shown that a brisk 30-minute walk can clear residual sclerosant from the treated segment, reduce local inflammatory by-products and maintain adequate flow through the deep system.
Put simply: walking is not an indicator of comfort. It is a dynamic haemodynamic intervention.
The compression requirement is where patients most commonly cut corners. Two weeks feels long. Stockings aren't comfortable in warm weather. By day four or five, the treated leg looks fine and feels manageable—so why keep going?
Because the process happening beneath the skin is still far from complete.
Medical-grade graduated compression stockings—typically prescribed at 20–30 mmHg following UGS—work by applying external circumferential pressure that reduces the cross-sectional diameter of superficial and deep veins. This has several clinically significant effects.
First, venous reflux is reduced by compression. In the post-procedure leg, the vein walls are inflamed and the sclerosant is still active. Any residual venous incompetence in adjacent vessels can lead to pooling of blood in the treated segment. This is mechanically restricted by compression, which keeps the blood flowing forward rather than allowing it to pool.
Second, interstitial oedema is reduced by compression. Sclerotherapy causes a local inflammatory reaction which results in localised capillary leakage - fluid leaking out of the vessels into the surrounding area. This swelling compresses local lymphatic channels and decreases the fluid clearance that the body needs to process the treated vein without enough compression. Sustained compression counteracts this by maintaining external pressure gradients that maintain venous return and lymphatic drainage.
Third—and this is the one most directly relevant to DVT risk—compression has been shown in multiple randomised controlled trials to reduce the incidence of superficial thrombophlebitis extending into the deep system after sclerotherapy. A 2019 systematic review in the *European Journal of Vascular and Endovascular Surgery* found that patients who wore compression consistently for two weeks post-UGS had significantly lower rates of deep venous thrombus extension compared to those who used compression for less than seven days.
Two weeks isn't an arbitrary number. It reflects the time window in which the treated vein transitions from an acutely inflamed, chemically irritated vessel to a stabilising fibrous structure. Until that stabilisation is sufficiently advanced, the risk profile remains elevated—and compression remains active medicine.
The long-haul flight and heavy exercise restrictions relate to a different set of risks, but the underlying physiology ties directly into everything above.
Long-haul flights, generally taken to mean flights in excess of four to six hours, expose passengers to conditions of prolonged immobility, low cabin humidity and reduced atmospheric pressure. Each of these factors decreases venous return individually. Together, they create conditions that significantly increase the risk of DVT in any patient. In someone with recent UGS, where the conditions of Virchow's Triad are already partly met, the added haemodynamic stress of a long flight can push a subclinical process into a clinical event. Most vascular specialists recommend avoiding flights longer than four hours for at least two weeks after the procedure.
Heavy resistance exercise introduces a different problem: intrathoracic pressure changes.
When you perform heavy compound lifts—squats, deadlifts, overhead presses—the Valsalva manoeuvre increases intra-abdominal and intrathoracic pressure significantly. This pressure is transmitted retrograde through the venous system, briefly opposing the return of blood from the lower limbs. In a healthy venous system with competent valves, this is tolerated well. In a post-sclerotherapy leg with inflamed, chemically disrupted vessels, the repeated retrograde pressure waves can mechanically stress the treated segment, potentially disrupting the early fibrous organisation of the collapsing vein.
This delays the conversion of the treated vessel into inert scar tissue—which directly affects the aesthetic outcome.
That last point is worth dwelling on, because it connects the medical risk management to the cosmetic result patients actually care about.
After UGS, the goal is clean fibrosis. You want the treated vein to collapse completely, form a uniform cord of scar tissue, and be gradually reabsorbed by the body over months. When this process goes smoothly, the vessel disappears. When it doesn't—when there's residual flow through the treated segment, or when the inflammatory process is disrupted by haemodynamic stress—the outcome is often pigmentation, a palpable cord that takes longer to resolve, or, in some cases, recanalisation of the vessel.
Walking, compression, and activity restrictions all protect the fibrosis process. They maintain the haemodynamic conditions that allow the treated vein to convert cleanly, without the interference that comes from venous stasis, pressure surges, or inadequate support to adjacent vessels.
Here's the part that's easy to miss.
The sclerotherapy procedure itself is only one part of what produces the outcome. The post-care protocol is the other part—and it's not supplementary. It's built into the clinical result.
Odyssey’s post-UGS rules are not conservative recommendations hedged for liability. They represent the true physiology of vein wall injury, inflammatory resolution, deep venous haemodynamics and DVT risk stratification. The calf muscle pump is activated by the 30-minute walk. The two weeks of compression preserves venous geometry, through the window of fibrosis. Avoiding flights and heavy lifting takes away the haemodynamic stressors which are most likely to interfere with clean vein conversion.
Follow the protocol, and your body can do exactly what the treatment set it up to do.
Skip it, and you're not just ignoring advice—you're working against the physiology.
The science is fairly clear on this one. Walk. Compress. Wait.
Now located at:
43 Glen Osmond Road
Eastwood SA 5063
